Initial Treatment for Hyperthyroidism in a Non-Pregnant 55-Year-Old Woman
The recommended initial treatment for hyperthyroidism in a non-pregnant 55-year-old woman is methimazole (antithyroid medication), typically started at a dose of 0.5-1.5 μg/kg/day. 1, 2
Diagnostic Confirmation
Before initiating treatment, confirm hyperthyroidism with:
- Thyroid function tests showing low TSH and elevated free T4 and/or free T3 2
- Determine the etiology (most commonly Graves' disease [70%] or toxic nodular goiter [16%]) 2
- Consider additional testing as needed:
- TSH-receptor antibodies
- Thyroid peroxidase antibodies
- Thyroid ultrasonography (especially if nodules are palpable)
- Thyroid scintigraphy (if etiology is unclear or nodules are present) 3
Treatment Protocol
First-Line Medication Approach
Start with methimazole:
Symptom management:
Monitoring:
Dose Adjustment
- Titrate methimazole in 12.5-25 mcg increments until TSH normalizes 1
- Target TSH within normal range (0.45-4.5 mIU/L) 1
- Once clinical evidence of hyperthyroidism resolves and TSH rises, reduce to maintenance dose 4
- Treatment duration typically 12-18 months for Graves' disease 7
Alternative Treatment Options
For patients who fail medical therapy, experience side effects, or have specific indications:
Radioactive iodine (RAI) therapy:
- Particularly effective for toxic nodular goiter 2
- Often preferred in older patients
- Results in permanent hypothyroidism requiring lifelong levothyroxine
Thyroidectomy:
- Consider for patients with large goiters causing compressive symptoms
- Appropriate for patients with suspicious nodules
- Requires preoperative achievement of euthyroid state with methimazole
Important Considerations and Monitoring
- Side effects of methimazole: Monitor for rash, arthralgias, and rare but serious agranulocytosis
- Long-term vs. short-term therapy: Recurrence after 12-18 month course occurs in approximately 50% of Graves' disease patients 2
- Risk factors for recurrence: Age <40 years, high initial free T4 (≥40 pmol/L), high TSH-binding inhibitory immunoglobulins, large goiter 2
- Complication monitoring: Assess for cardiac arrhythmias, heart failure, and osteoporosis 3
Special Situations
- Thyroid storm: Medical emergency requiring hospitalization, IV therapy, and supportive care 1
- Elderly patients: May require lower initial doses (25-50 mcg/day) with slower titration to avoid cardiac complications 1
- Drug interactions: Adjust dosing of anticoagulants, β-blockers, digitalis, and theophylline when transitioning from hyperthyroid to euthyroid state 4